Literature DB >> 8586995

Oligodendrocyte survival and function in the long-lived strain of the myelin deficient rat.

I D Duncan1, N L Nadon, R L Hoffman, K F Lunn, C Csiza, M R Wells.   

Abstract

This study has examined cellular and molecular aspects of glial cell function in a newly described long-lived myelin deficient rat mutant. In contrast to the shorter-lived mutants which died at 25-30 days, the longer-lived mutant rats lived to 75-80 days of age. Despite living longer, these mutants had a similar frequency of seizures to their younger counterparts. In the spinal cord and optic nerves of the older mutants, myelinated fibres in similar numbers to those seen in the younger myelin deficient rats were present. However, the total glial cell numbers were markedly reduced with few remaining normal appearing oligodendrocytes, and very few microglia compared to the younger mutants. In addition, little or no cell death or division was seen in the longer-lived rats. However, there was some evidence of ongoing myelination and the persistence of immature oligodendrocytes or their progenitors in the older mutant. There was some continued myelin gene expression, although this was at much reduced levels compared to normal, with proteolipid protein and myelin basic protein being most affected. In situ hybridization analysis for proteolipid protein mRNA showed that few proteolipid protein expressing oligodendrocytes remained in the 70-80-day-old mutant. Polymerase chain reaction analysis of exon 3 of the long-lived mutant revealed the same point mutation as described in the younger myelin deficient rat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586995     DOI: 10.1007/bf01191211

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  10 in total

1.  Proteolipid protein regulates the survival and differentiation of oligodendrocytes.

Authors:  X Yang; R P Skoff
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

Review 2.  Schwann cell invasion of the central nervous system of the myelin mutants.

Authors:  I D Duncan; R L Hoffman
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

3.  Cellular compensatory mechanisms in the CNS of dysmyelinated rats.

Authors:  Jacek M Kwiecien
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

4.  Endpoints in myelin-deficient (MD) rats.

Authors:  Jacek M Kwiecien; Kathleen H Delaney
Journal:  Comp Med       Date:  2010-10       Impact factor: 0.982

5.  Transplanted human glial-restricted progenitors can rescue the survival of dysmyelinated mice independent of the production of mature, compact myelin.

Authors:  Agatha Lyczek; Antje Arnold; Jiangyang Zhang; James T Campanelli; Miroslaw Janowski; Jeff W M Bulte; Piotr Walczak
Journal:  Exp Neurol       Date:  2017-02-02       Impact factor: 5.330

Review 6.  The myelin mutants as models to study myelin repair in the leukodystrophies.

Authors:  Ian D Duncan; Yoichi Kondo; Su-Chun Zhang
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

7.  Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination.

Authors:  Chelsey M Smith; Elizabeth Cooksey; Ian D Duncan
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

8.  Autophagy promotes oligodendrocyte survival and function following dysmyelination in a long-lived myelin mutant.

Authors:  Chelsey M Smith; Joshua A Mayer; Ian D Duncan
Journal:  J Neurosci       Date:  2013-05-01       Impact factor: 6.167

Review 9.  Inherited and acquired disorders of myelin: The underlying myelin pathology.

Authors:  Ian D Duncan; Abigail B Radcliff
Journal:  Exp Neurol       Date:  2016-04-09       Impact factor: 5.330

10.  Activin receptors regulate the oligodendrocyte lineage in health and disease.

Authors:  Alessandra Dillenburg; Graeme Ireland; Rebecca K Holloway; Claire L Davies; Frances L Evans; Matthew Swire; Marie E Bechler; Daniel Soong; Tracy J Yuen; Gloria H Su; Julie-Clare Becher; Colin Smith; Anna Williams; Veronique E Miron
Journal:  Acta Neuropathol       Date:  2018-02-03       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.